To keep up-to-date with discussions you can subscribe to all postings by clicking the subscribe button below. You can manage your network notifications and set the frequency of emails in your communication preference area.
Return to previous page
In order for a medicine to be authorised by a regulatory authority for use in the UK, the benefits and risks of a medicines are carefully considered. As it is impossible for absolutely all information about a medicine to be known prior to it being authorised, a balance must be struck between making a new medicine available to patients and having adequate information on a product's quality, safety and efficacy. Once a medicine is launched, ongoing safety monitoring is crucial, as at the time the marketing authorisation is granted the medicine will have been tested in a relatively small number of patients for a limited amount of time.
Click here for more information
Need help with networks?
If you have any queries about our networks you can get in touch via:
Networks – [email protected]
Local Practice Forums (LPFs) - [email protected]
If you need to report a post then please use the report button within a discussion.